Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Many children with alopecia areata also have other autoimmune diseases.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Children with alopecia areata have lower BDNF levels, linked to worse symptoms and quality of life.

Current treatments for alopecia areata can help hair grow but don't cure the disease.

People with alopecia areata often have lower iron levels than healthy people.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

Essential oils like lavender, chamomile, and bergamot help manage stress and improve well-being.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Effective treatments for severe alopecia areata are still lacking.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Diffuse unpatterned alopecia can affect donor areas, but treatment with finasteride and minoxidil can improve hair density.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Exosomes helped regrow hair in a 14-year-old with difficult-to-treat alopecia.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.